{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:43:39Z","timestamp":1768592619236,"version":"3.49.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening disease for which pregnancy and the postpartum period represent risk factors. Here, we present the case of a 39-year-old woman at the 31st week of gestation, who presented with cutaneous haemorrhagic symptoms. The complete blood count showed anaemia, thrombocytopenia, increase in haemolysis indices and undetectable ADAMTS13 activity. Acquired TTP was diagnosed, and she started daily plasma exchange (PEX) and methylprednisolone. After 5\u200adays, an emergency caesarean section was performed with success because of pathologic cardiotocographic findings. After 7 days of PEX, the patient showed an initial laboratoristic improvement; unfortunately, 3 days later, she had a recurrence of disease and started daily PEX, caplacizumab and steroid, obtaining a haematological improvement.<\/jats:p>\n            <jats:p>No literature data about caplacizumab use in pregnant or breastfeeding patients are available. In the present study, we describe that caplacizumab in the postpartum period could be well tolerated and effective.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mbc.0000000000001186","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T20:25:50Z","timestamp":1675369550000},"page":"215-217","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum period"],"prefix":"10.1097","volume":"34","author":[{"given":"Antonella","family":"Bruzzese","sequence":"first","affiliation":[{"name":"Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Vigna","sequence":"additional","affiliation":[{"name":"Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica Antonia","family":"Martino","sequence":"additional","affiliation":[{"name":"Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Mendicino","sequence":"additional","affiliation":[{"name":"Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Lucia","sequence":"additional","affiliation":[{"name":"Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Olivito","sequence":"additional","affiliation":[{"name":"Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Mazzulla","sequence":"additional","affiliation":[{"name":"Gynecology and Ostetric Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"De Rose","sequence":"additional","affiliation":[{"name":"Gynecology and Ostetric Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Pasquale","family":"Cozza","sequence":"additional","affiliation":[{"name":"Gynecology and Ostetric Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Bova","sequence":"additional","affiliation":[{"name":"Internal Medicine Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Filippelli","sequence":"additional","affiliation":[{"name":"Direzione Generale"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Zinno","sequence":"additional","affiliation":[{"name":"SIMT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Morelli","sequence":"additional","affiliation":[{"name":"Gynecology and Ostetric Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[{"name":"Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[{"name":"Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"R1-20250617","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood.2019000962","article-title":"How I treat thrombotic thrombocytopenic purpura in pregnancy","volume":"136","author":"Ferrari","year":"2020","journal-title":"Blood"},{"key":"R2-20250617","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1160\/TH03-11-0683","article-title":"Von Willebrand factor-cleaving protease (ADAMTS13) activity in normal nonpregnant women, pregnant and postdelivery women","volume":"92","author":"S\u00e1nchez-Luceros","year":"2004","journal-title":"Thromb Haemost"},{"key":"R3-20250617","first-page":"1029","article-title":"Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome","volume":"88","author":"Lattuada","year":"2003","journal-title":"Haematologica"},{"key":"R4-20250617","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/ATVBAHA.111.223610","article-title":"ECLAXIR Study Group. Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology","volume":"31","author":"Stepanian","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R5-20250617","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"key":"R6-20250617","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"French Reference Center for Thrombotic Microangiopathies. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"key":"R7-20250617","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R8-20250617","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"key":"R9-20250617","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.mbc.0000240918.65306.20","article-title":"Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura","volume":"17","author":"Scully","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R10-20250617","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13256-018-1692-1","article-title":"Post-partum thrombotic thrombocytopenic purpura (TTP) in a patient with known idiopathic (immune) thrombocytopenic purpura: a case report and review of the literature","volume":"12","author":"Al-Husban","year":"2018","journal-title":"J Med Case Rep"},{"key":"R11-20250617","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"R12-20250617","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"HERCULES Investigators. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000001186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:08:51Z","timestamp":1750201731000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000001186","relation":{},"ISSN":["0957-5235","1473-5733"],"issn-type":[{"value":"0957-5235","type":"print"},{"value":"1473-5733","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]}}}